PRELUDE THERAPEUTICS INC
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-83.5M | $-85.9M | $2.3M | $20.9M |
| FY2022 | $-83.7M | $-86.7M | $3.0M | $25.1M |
| FY2023 | $-107.1M | $-110.6M | $3.5M | $25.6M |
| FY2024 | $-102.9M | $-103.7M | $764.0K | $21.3M |
| FY2025 | $-56.3M | $-56.4M | $67.0K | $11.9M |